Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.69B P/E - EPS this Y -12.10% Ern Qtrly Grth -
Income -30.44M Forward P/E -65.40 EPS next Y 23.00% 50D Avg Chg 13.00%
Sales 399.24M PEG -1.56 EPS past 5Y - 200D Avg Chg 28.00%
Dividend N/A Price/Book 5.83 EPS next 5Y 20.00% 52W High Chg -5.00%
Recommedations 1.90 Quick Ratio 2.55 Shares Outstanding 48.37M 52W Low Chg 75.00%
Insider Own 3.08% ROA -3.24% Shares Float 46.01M Beta 1.37
Inst Own 100.80% ROE -6.60% Shares Shorted/Prior 3.25M/2.37M Price 56.90
Gross Margin 75.24% Profit Margin -7.62% Avg. Volume 291,016 Target Price 56.14
Oper. Margin -12.28% Earnings Date May 1 Volume 376,693 Change 1.16%
About AtriCure, Inc.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

AtriCure, Inc. News
04/10/24 AtriCure to Announce First Quarter 2024 Financial Results
03/26/24 AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/22/24 AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
03/07/24 Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)
02/28/24 AtriCure (ATRC) Fell on Competitor Action
09:25 AM AtriCure Full Year 2023 Earnings: EPS Beats Expectations
02/16/24 AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript
02/16/24 Q4 2023 AtriCure Inc Earnings Call
02/15/24 Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings
02/15/24 AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates
02/15/24 AtriCure Inc (ATRC) Reports Strong Revenue Growth in Q4 and Full Year 2023
02/15/24 AtriCure: Q4 Earnings Snapshot
02/15/24 AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
02/12/24 Seeking Clues to AtriCure (ATRC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
01/25/24 AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference
01/08/24 AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024
01/04/24 AtriCure Appoints Shlomi Nachman to the Board of Directors
01/03/24 AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price
12/20/23 AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
11/15/23 Wall Street Analysts Predict a 36.34% Upside in AtriCure (ATRC): Here's What You Should Know
ATRC Chatroom

User Image Stock_Titan Posted - 1 week ago

$ATRC AtriCure to Announce First Quarter 2024 Financial Results https://www.stocktitan.net/news/ATRC/atri-cure-to-announce-first-quarter-2024-financial-d7fuh6h7jh10.html

User Image Thestocktraderhubzee Posted - 1 week ago

WATCHLIST APR 10 2024.. $AUTL Truist Securities Maintains Buy on Autolus Therapeutics, Raises Price Target to $11 $ATRC Needham Reiterates Buy on AtriCure, Maintains $46 Price Target $UDR Truist Securities Maintains Buy on UDR, Lowers Price Target to $42 $ESS Truist Securities Maintains Hold on Essex Property Trust, Lowers Price Target to $255 $EQR Truist Securities Maintains Buy on Equity Residential, Lowers Price Target to $67

User Image insiderbuyingselling Posted - 2 weeks ago

$ATRC new insider selling: 1500 shares. http://insiderbuyingselling.com/?t=ATRC

User Image Stock_Titan Posted - 03/26/24

$ATRC AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/ATRC/atri-cure-to-participate-in-the-23rd-annual-needham-virtual-cjtzoixjpz6q.html

User Image Office21 Posted - 03/20/24

$ATRC brutal

User Image insiderbuyingselling Posted - 03/20/24

$ATRC new insider selling: 1885 shares. http://insiderbuyingselling.com/?t=ATRC

User Image drknmstr01 Posted - 1 month ago

$ATRC Starting DD

User Image insiderbuyingselling Posted - 1 month ago

$ATRC new insider selling: 1500 shares. http://insiderbuyingselling.com/?t=ATRC

User Image insiderbuyingselling Posted - 1 month ago

$ATRC new insider selling: 8231 shares. http://insiderbuyingselling.com/?t=ATRC

User Image TickerDD_com Posted - 02/21/24

From 2/20/2024, looking back across 22 Month-Ends for ATRC, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ATRC #ATRC #ATRCStock #TickerDD #ATRCPrice https://www.youtube.com/watch?v=njYOQeHFiTQ

User Image Fullratio Posted - 02/20/24

$ATRC revenue is up by 21% year-on-year and by 4.9% since the previous quarter: https://fullratio.com/stocks/nasdaq-atrc/atricure

User Image Fullratio Posted - 2 months ago

$ATRC gross profit rose by 22% YoY and by 5% QoQ: https://fullratio.com/stocks/nasdaq-atrc/atricure

User Image swingingtech Posted - 2 months ago

$TOST $COIN $ATRC $WEST https://wallstreetwaves.com/coinbase-to-rally-around-45-here-are-10-top-analyst-forecasts-for-friday/

User Image Office21 Posted - 2 months ago

$ATRC let’s see this thing pop tomorrow. Long-term hold

User Image Estimize Posted - 2 months ago

$ATRC beats the Estimize EPS Consensus by 1c and the Estimize Revenue Consensus by $0.30M. Reports FQ4 earnings of -21c EPS and $106.54... http://www.estimize.com/atrc/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image epsguid Posted - 2 months ago

$ATRC reported a loss of $0.21, consensus was ($0.22) via @eWhispers #epsbeat http://eps.sh/d/atrc

User Image DonCorleone77 Posted - 2 months ago

$ATRC AtriCure reports Q4 EPS (21c), consensus (23c) Reports Q4 revenue $106.5M, consensus $103.7M. "Our 2023 results showcase the broad-based expansion of our many growth drivers, balanced by disciplined investments as we make progress towards sustained profitability," said Michael Carrel, President and Chief Executive Officer at AtriCure. "We begin 2024 with strong momentum throughout our business and an unwavering focus on advancing innovation, clinical science and therapy awareness as we establish new standards of care for patients globally."

User Image Stock_Titan Posted - 2 months ago

$ATRC AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results https://www.stocktitan.net/news/ATRC/atri-cure-reports-fourth-quarter-2023-and-full-year-2023-financial-butfgdjpfsk5.html

User Image Estimize Posted - 2 months ago

$ATRC reports after the close, Estimize Consensus +0.01 EPS and +2.57M Revs compared to WS http://www.estimize.com/atrc/fq4-2023?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image VirmoMopire Posted - 01/30/24

$ATRC Just spotted some interesting activity on this one. 🧐

User Image tickeron Posted - 01/23/24

A.I.dvisor is predicting $ATRC is about to fall. View odds of downtrend. https://srnk.us/go/4976594

User Image tickeron Posted - 3 months ago

Does this make you nervous? $ATRC MACD Histogram turned positive on January 11, 2024. View odds of downtrend. https://srnk.us/go/4966622

User Image EarningsInsider Posted - 3 months ago

$ATRC updates Q4 2023 guidance to EPS and revenue guidance to $106.5 million-$106.5 million. www.marketbeat.com/stocks/NASDAQ/ATRC/earnings

User Image EarningsInsider Posted - 3 months ago

$ATRC updates FY 2023 guidance to EPS and revenue guidance to $399.2 million-$399.2 million. www.marketbeat.com/stocks/NASDAQ/ATRC/earnings

User Image EarningsInsider Posted - 3 months ago

$ATRC updates FY 2024 guidance to EPS and revenue guidance to $459.0 million-$466.0 million. www.marketbeat.com/stocks/NASDAQ/ATRC/earnings

User Image BettyLeclaire Posted - 3 months ago

$CHK $HELE $ATRC $VIXY ACCOUNT CHALLENGE UPDATE: Starting Balance: $3,700 Current Balance: $54,873 Goal: $100K by end of Jan. Watch out for our next alert!-..,πŸ’– top-stocks-winning-great-us.blogspot.com/2023/11/blog-post.html

User Image ErmaLong Posted - 3 months ago

$ATRC $GBTC $CVRX $SIBN Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining!~...πŸ’– top-stocks-winning-great-us.blogspot.com/2023/11/blog-post.html

User Image cctranscripts Posted - 3 months ago

AtriCure director just declared 0 ownership of the company. https://www.conferencecalltranscripts.org/summary/?id=12849384 $ATRC

User Image cctranscripts Posted - 3 months ago

AtriCure director just picked up 5,322 shares https://www.conferencecalltranscripts.org/summary/?id=12849406 $ATRC

User Image EarningsInsider Posted - 3 months ago

$ATRC updates FY23 guidance to ($0.76)-($0.74) EPS. www.marketbeat.com/stocks/NASDAQ/ATRC/earnings/

Analyst Ratings
Needham Buy Apr 10, 24
UBS Buy Feb 16, 24
Stifel Buy Feb 16, 24
Needham Buy Feb 16, 24
Needham Buy Jan 4, 24
JMP Securities Market Outperform Nov 29, 23
Needham Buy Nov 29, 23
JP Morgan Overweight Nov 2, 23
Needham Buy Nov 2, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dahlquist Karl S. Chief Legal Officer Chief Legal Officer Nov 01 Sell 34.43 1,248 42,969 30,789 11/03/23
Dahlquist Karl S. Chief Legal Officer Chief Legal Officer Jul 26 Sell 57.09 3,417 195,077 32,037 07/28/23
Prange Karen Director Director Jun 08 Sell 47.89 713 34,146 16,140 06/12/23
Dahlquist Karl S. Chief Legal Officer Chief Legal Officer Jun 06 Sell 47.03 1,422 66,877 34,897 06/07/23
Yuen Maggie Director Director May 26 Sell 47.04 4,313 202,884 4,682 05/30/23
Collar Mark A Director Director Mar 13 Option 9.30 10,000 93,000 100,871 03/15/23
WHITE ROBERT S. Director Director Aug 31 Option 8.48 15,000 127,200 55,799 09/02/22
Austin Tonya Chief Human Resource.. Chief Human Resources Officer May 13 Sell 42.69 3,203 136,736 17,621 05/17/22
Austin Tonya Chief Human Resource.. Chief Human Resources Officer Apr 08 Sell 61.59 282 17,368 20,824 04/12/22
Collar Mark A Director Director Mar 16 Option 8.40 10,000 84,000 87,307 03/18/22
WHITE ROBERT S. Director Director Mar 03 Option 8.48 15,000 127,200 37,235 03/07/22
Austin Tonya Chief Human Resource.. Chief Human Resources Officer Mar 04 Sell 67.66 1,409 95,333 21,106 03/07/22
Austin Tonya Chief Human Resource.. Chief Human Resources Officer Mar 02 Sell 69.86 4,885 341,266 22,515 03/04/22
Austin Tonya Chief Human Resource.. Chief Human Resources Officer Feb 11 Sell 67.97 2,490 169,245 20,340 02/15/22
Austin Tonya Chief Human Resource.. Chief Human Resources Officer Jan 14 Sell 66.11 2,719 179,753 22,830 01/18/22
WEHRWEIN SVEN Director Director May 05 Option 19.95 5,000 99,750 17,686 05/05/21
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Feb 04 Option 21.04 25,000 526,000 529,795 02/04/21
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Feb 04 Sell 60 25,000 1,500,000 504,795 02/04/21
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Jan 13 Option 21.04 25,000 526,000 529,795 01/13/21
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Jan 13 Sell 59 25,000 1,475,000 504,795 01/13/21
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Dec 28 Option 21.04 25,000 526,000 529,457 12/28/20
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Dec 28 Sell 58 25,000 1,450,000 504,504 12/28/20
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Dec 23 Option 21.04 74,751 1,572,761 529,504 12/23/20
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Dec 23 Sell 56 74,751 4,186,056 504,504 12/23/20
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Dec 21 Option 13.48 125,249 1,688,357 554,753 12/21/20
CARREL MICHAEL H President, CEO, & Di.. President, CEO, & Director Dec 21 Sell 51.63 125,249 6,466,606 504,504 12/21/20